The gastric effects of UFP-112, a new nociceptin/orphanin receptor agonist, in physiological and pathological conditions

被引:14
作者
Broccardo, M.
Guerrini, R.
Morini, G.
Polidori, C.
Agostini, S.
Petrella, C.
Improta, G.
机构
[1] Univ Roma La Sapienza, Dipartimento Fisiol Umana & Farmacol V Erspramer, I-00185 Rome, Italy
[2] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[3] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[4] Univ Parma, Dept Human Anat Pharmacol & Forens Med, I-43100 Parma, Italy
[5] Univ Camerino, Dept Pharmacol Sci & Expt Med, I-62032 Camerino, Italy
关键词
UFP-112; gastric emptying; secretion and ulcers;
D O I
10.1016/j.peptides.2007.07.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Nociceptin/orphanin FQ (N/OFQ), the endogenous NOP receptor ligand, centrally modulates gastric motor and secretory functions and prevents ethanol-induced gastric lesions in rats. A recently synthesized N/OFQ analog, [(pF)Phe(4)Aib(7)Arg(14)Lys(15)]N/OFQ-NH2 (UFP-112), acts as a highly potent and selective peptide agonist for NOP receptors and produces longer-lasting in vitro and in vivo effects in mice than the natural ligand N/OFQ. In this study, we evaluated the effects of centrally (intracerebroventricularly/icv) and peripherally (intraperitoneally/ip) injected UFP-112 on gastric emptying and gastric acid secretion, and on the development of gastric mucosal lesions induced by 50% ethanol in the rat. When injected icv, it dose-dependently delayed gastric emptying of a phenol red meal (by up to 70%), decreased gastric secretion in water-loaded rats after 90 pylorus ligature, and reduced ethanol-induced gastric lesions (by up to 87%). In all three assays, UFP-112 was more effective than N/OFQ. The highly selective NOP receptor antagonist, UFP-101, decreased the efficacy of UFP-112, thus confirming that central NOP receptors mediate inhibitory control on these functional and pathological conditions in rats. Ip injected N/OFQ and UFP-112 induced non-dose-related gastric hypersecretory and antiulcer effects, which UFP-101 partially abolished. Ip N/OFQ appeared equiactive but about 30-100 times less potent than ip UFP-112 in stimulating gastric acid secretion and preventing lesion formation. When ip injected, both UFP-112 and N/OFQ left gastric emptying in rats unchanged, suggesting that peripheral NOP receptors have a role in mediating gastric hypersecretory and antiulcer effects but are not involved in regulating gastric motility. In addition, the inhibitory effects induced by this novel NOP receptor agonist lasted longer than those induced by N/OFQ In conclusion, UFP-112 is a promising new pharmacological tool for studying the functional roles of the central and peripheral N/OFQ receptor system. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1974 / 1981
页数:8
相关论文
共 28 条
[1]
Anton B, 1996, J COMP NEUROL, V368, P229
[2]
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids [J].
Arduin, Marika ;
Spagnolo, Barbara ;
Calo, Girolamo ;
Guerrini, Remo ;
Carra, Giacomo ;
Fischetti, Carmela ;
Trapella, Claudio ;
Marzola, Erika ;
McDonald, John ;
Lambert, David G. ;
Regoli, Domenico ;
Salvadori, Severo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (13) :4434-4443
[3]
The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions [J].
Broccardo, A ;
Linari, G ;
Guerrini, R ;
Agostini, S ;
Petrella, C ;
Improta, G .
PEPTIDES, 2005, 26 (09) :1590-1597
[4]
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors [J].
Broccardo, M ;
Scaccianoce, S ;
Del Bianco, P ;
Agostini, S ;
Petrella, C ;
Improta, G .
NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (06) :871-877
[5]
Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats [J].
Broccardo, M ;
Guerrini, R ;
Petrella, C ;
Improta, G .
PEPTIDES, 2004, 25 (06) :1013-1020
[6]
MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE [J].
BUNZOW, JR ;
SAEZ, C ;
MORTRUD, M ;
BOUVIER, C ;
WILLIAMS, JT ;
LOW, M ;
GRANDY, DK .
FEBS LETTERS, 1994, 347 (2-3) :284-288
[7]
Calo G, 2005, CNS DRUG REV, V11, P97
[8]
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor [J].
Calo, G ;
Rizzi, A ;
Rizzi, D ;
Bigoni, R ;
Guerrini, R ;
Marzola, G ;
Marti, M ;
McDonald, J ;
Morari, M ;
Lambert, DG ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (02) :303-311
[9]
Pharmacology of nociceptin and its receptor: a novel therapeutic target [J].
Calo, G ;
Guerrini, R ;
Rizzi, A ;
Salvadori, S ;
Regoli, D .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (07) :1261-1283
[10]
Autoradiographic localization of [3H]nociceptin binding sites in the rat brain [J].
Florin, S ;
Meunier, JC ;
Costentin, J .
BRAIN RESEARCH, 2000, 880 (1-2) :11-16